Publications dans lesquelles il/elle collabore avec JUAN JOSÉ DÍAZ MOCHÓN (7)

2021

  1. Cross‐resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by ar transcriptional reactivation

    Cancers, Vol. 13, Núm. 6, pp. 1-21

2020

  1. Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

    Critical Reviews in Oncology/Hematology, Vol. 151

  2. Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

    Critical Reviews in Oncology/Hematology

  3. Precision prevention and cancer interception: The new challenges of liquid biopsy

    Cancer Discovery, Vol. 10, Núm. 11, pp. 1635-1644

2019

  1. Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity

    Critical Reviews in Oncology/Hematology, Vol. 136, pp. 31-36

2015

  1. MiRNA in situ hybridization in circulating tumor cells - MishCTC

    Scientific Reports, Vol. 5

  2. Study of antitumor activity in breast cell lines using silver nanoparticles produced by yeast

    International Journal of Nanomedicine, Vol. 10, pp. 2021-2031